References
- The Global Asthma Report 2022. Int J Tuberc Lung Dis. 2022;26:1–102.
- Louis R, Satia I, Ojanguren I, Schleich F, Bonini M, Tonia T, Rigau D, ten Brinke A, Buhl R, Loukides S, et al. European respiratory society guidelines for the diagnosis of asthma in adults. Eur Respir J. 2022;60(3):2101585. doi:10.1183/13993003.01585-2021.
- Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1204–1222. doi:10.1016/S0140-6736(20)30925-9.
- OECD/EU 2022. Health at a Glance: Europe 2022: state of Health in the EU Cycle, OECD Publishing, Paris. Available from: https://www.oecd-ilibrary.org/docserver/507433b0-en.pdf?expires=1684438131&id=id&accname=guest&checksum=38EE450C1739DD0C1AAE1DAE9FE0BBA5 [last accessed 18 May 2023].
- Nurmagambetov T, Kuwahara R, Garbe P. The economic burden of asthma in the United States, 2008-2013. Ann Am Thorac Soc. 2018;15(3):348–356. doi:10.1513/AnnalsATS.201703-259OC.
- Yaghoubi M, Adibi A, Safari A, FitzGerald JM, Sadatsafavi M. The projected economic and health burden of uncontrolled asthma in the United States. Am J Respir Crit Care Med. 2019;200(9):1102–1112. doi:10.1164/rccm.201901-0016OC.
- Kuruvilla ME, Lee FE, Lee GB. Understanding asthma phenotypes, endotypes, and mechanisms of disease. Clin Rev Allergy Immunol. 2019;56(2):219–233. doi:10.1007/s12016-018-8712-1.
- Guida G, Bagnasco D, Carriero V, Bertolini F, Ricciardolo FLM, Nicola S, Brussino L, Nappi E, Paoletti G, Canonica GW, et al. Critical evaluation of asthma biomarkers in clinical practice. Front Med (Lausanne). 2022;9:969243. doi:10.3389/fmed.2022.969243.
- Drake SM, Simpson A, Fowler SJ. Asthma diagnosis: the changing face of guidelines. Pulm Ther. 2019;5(2):103–115. doi:10.1007/s41030-019-0093-y.
- Cunha F, Amaral R, Jacinto T, Sousa-Pinto B, Fonseca JA. A systematic review of asthma phenotypes derived by data-driven methods. Diagnostics (Basel). 2021;11(4):644. doi:10.3390/diagnostics11040644.
- Kaur R, Chupp G. Phenotypes and endotypes of adult asthma: moving toward precision medicine. J Allergy Clin Immunol. 2019;144(1):1–12. doi:10.1016/j.jaci.2019.05.031.
- Moore WC, Meyers DA, Wenzel SE, Teague WG, Li H, Li X, D’Agostino R, Castro M, Curran-Everett D, Fitzpatrick AM, et al. Identification of asthma phenotypes using cluster analysis in the severe asthma research program. Am J Respir Crit Care Med. 2010;181(4):315–323. doi:10.1164/rccm.200906-0896OC.
- Kavanagh J, Jackson DJ, Kent BD. Over- and under-diagnosis in asthma. Breathe (Sheff). 2019;15(1):e20–e27. doi:10.1183/20734735.0362-2018.
- Agusti A, Bel E, Thomas M, Vogelmeier C, Brusselle G, Holgate S, Humbert M, Jones P, Gibson PG, Vestbo J, et al. Treatable traits: toward precision medicine of chronic airway diseases. Eur Respir J. 2016;47(2):410–419. doi:10.1183/13993003.01359-2015.
- Ricciardolo FLM, Carriero V, Bertolini F. Biomarkers in asthma. In: Encyclopedia of respiratory medicine. Amsterdam, Netherlands: Elsevier; 2022:342–351. Available from: https://linkinghub.elsevier.com/retrieve/pii/B9780081027233001013.
- Tiotiu A. Biomarkers in asthma: state of the art. Asthma Res Pract. 2018;4:10.
- Canonica GW, Ferrando M, Baiardini I, Puggioni F, Racca F, Passalacqua G, Heffler E. Asthma: personalized and precision medicine. Curr Opin Allergy Clin Immunol. 2018;18(1):51–58. doi:10.1097/ACI.0000000000000416.
- Haldar P, Pavord ID, Shaw DE, Berry MA, Thomas M, Brightling CE, Wardlaw AJ, Green RH. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med. 2008;178(3):218–224. doi:10.1164/rccm.200711-1754OC.
- McDonald VM, Gibson PG. Treatable traits in asthma: moving beyond diagnostic labels. Med J Aust. 2022;216(7):331–333. doi:10.5694/mja2.51464.
- Pavord ID, Beasley R, Agusti A, Anderson GP, Bel E, Brusselle G, Cullinan P, Custovic A, Ducharme FM, Fahy JV, et al. After asthma: redefining airways diseases. Lancet. 2018;391(10118):350–400. doi:10.1016/S0140-6736(17)30879-6.
- Reddel HK, FitzGerald JM, Bateman ED, Bacharier LB, Becker A, Brusselle G, Buhl R, Cruz AA, Fleming L, Inoue H, et al. GINA 2019: a fundamental change in asthma management: treatment of asthma with short-acting bronchodilators alone is no longer recommended for adults and adolescents. Eur Respir J. 2019;53(6):1901046. doi:10.1183/13993003.01046-2019.
- Moynihan R, Doust J, Henry D. Preventing overdiagnosis: how to stop harming the healthy. BMJ. 2012;344:e3502. doi:10.1136/bmj.e3502.
- Thorley J. NICE issues draft guideline for asthma diagnosis. Lancet Respir Med. 2015;3(3):184. doi:10.1016/S2213-2600(15)00038-7.
- de Abreu FC, da Silva Júnior JLR, Rabahi MF. The fraction exhaled nitric oxide as a biomarker of asthma control. Biomark Insights. 2019;14:1177271919826550. doi:10.1177/1177271919826550.
- Aaron SD, Vandemheen KL, FitzGerald JM, Ainslie M, Gupta S, Lemière C, Field SK, McIvor RA, Hernandez P, Mayers I, et al. Reevaluation of diagnosis in adults with physician-diagnosed asthma. JAMA. 2017;317(3):269–279. doi:10.1001/jama.2016.19627.
- Armeftis C, Lemessios M, Anastasiades C, et al. Is asthma over-diagnosed in Cyprus? A clinical study at the outpatient’s primary care level. Open J Asthma. 2022;6(1):001–007.
- Shaw D, Green R, Berry M, Mellor S, Hargadon B, Shelley M, McKenna S, Thomas M, Pavord I. A cross-sectional study of patterns of airway dysfunction, symptoms and morbidity in primary care asthma. Prim Care Respir J. 2012;21(3):283–287. doi:10.4104/pcrj.2012.00057.
- Pakhale S, Sumner A, Coyle D, Vandemheen K, Aaron S. (Correcting) misdiagnoses of asthma: a cost effectiveness analysis. BMC Pulm Med. 2011;11:27. doi:10.1186/1471-2466-11-27.
- de Marco R, Cerveri I, Bugiani M, Ferrari M, Verlato G. An undetected burden of asthma in Italy: the relationship between clinical and epidemiological diagnosis of asthma. Eur Respir J. 1998;11(3):599–605. doi:10.1183/09031936.98.11030599.
- Nolte H, Nepper-Christensen S, Backer V. Unawareness and undertreatment of asthma and allergic rhinitis in a general population. Respir Med. 2006;100(2):354–362. doi:10.1016/j.rmed.2005.05.012.
- Kroegel C, Wirtz H. History of guidelines for the diagnosis and management of asthma: from opinion to control. Drugs. 2009;69(9):1189–1204. doi:10.2165/00003495-200969090-00004.
- Woolcock A, Seale JP, Rubinfeld AR, Landau LL, Antic R, Mitchell C, Rea HH, Zimmerman P. Thoracic society of Australia and New Zealand. Asthma management plan, 1989. Med J Aust. 1989;151(11-12):650–653. doi:10.5694/j.1326-5377.1989.tb139640.x.
- Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention NHLBI/WHO Workshop Report (Based on a March 1993 Meeting). 1995. Available from: https://ginasthma.org/wp-content/uploads/2019/01/1995-GINA.pdf [last accessed 25 March 2023].
- British guideline on the management of asthma. A national clinical guideline. Healthcare Improvement Scotland. Scottish Intercollegiate Guidelines Network British Thoracic Society. 2016. Available from: file:///C:/Users/USER/Downloads/BTS_SIGN%20Asthma%20Guideline%202016%20(1).pdf [last accessed 25 March 2023].
- BTS/SIGN British Guideline on the Management of Asthma. Available from: https://www.brit-thoracic.org.uk/news/2021/nicebtssign-joint-asthma-guideline-update-public-consultation-on-scope-and-committee-members-recruitment/ [last accessed 25 March 2023].
- Asthma: diagnosis and monitoring of asthma in adults, children and young people. NICE. November 2017. Available from: https://www.nice.org.uk/guidance/ng80/evidence/asthma-diagnosis-and-monitoring-of-asthma-in-adults-children-and-young-people-pdf-7079863936 [last accessed 25 March 2023].
- Asthma: diagnosis, monitoring and chronic asthma management. NICE. March 22, 2021. Available from: https://www.nice.org.uk/guidance/ng80 [last accessed 25 March 2023].
- 2022 GINA Main Report, Global strategy for asthma management and prevention. Available from: https://ginasthma.org/gina-reports/ [last accessed 25 March 2023].